GLP-4
The metabolic advantage of injection, without the needle.
GLP-1 receptor agonists work. The delivery method, daily subcutaneous injection with significant nausea and muscle loss, is not a sustainable protocol for most people. GLP-4 delivers pharmaceutical-grade NAD+ through transmucosal absorption, bypassing digestion entirely.
NAD+ (10mg per spray)
One coenzyme, central to metabolism. NAD+ is the molecule your cells depend on to convert fuel into energy, regulate glucose, activate longevity pathways, and mobilize stored fat. Delivered intranasally or sublingually for absorption that bypasses first-pass metabolism.
Mitochondrial output
NAD+ is the primary electron carrier in cellular respiration. It drives the energy substrate cycle for sustained output rather than stimulant-driven peaks.
Glucose regulation
NAD+ supports insulin signaling and glucose handling, targeting the post-meal dynamics that drive fat storage and energy crashes.
Longevity genes
Sirtuins (SIRT1, SIRT3) are NAD-dependent enzymes. Without NAD+ they cannot fire. This is the same longevity mechanism caloric restriction activates, metabolic efficiency at the gene expression level.
Fat mobilization
By restoring the metabolic machinery that releases stored fatty acids for energy, NAD+ supports the fat-mobilization cascade, replicating part of what injectable GLP-1 agonists achieve.
A single active compound: pharmaceutical-grade NAD+ at 10mg per spray, 100 sprays per bottle (1,000mg total). No fillers, no stimulants, no proprietary blends.
GLP-4 delivers NAD+ through a non-injection route. It is not a pharmaceutical substitute, it is a precision metabolic support protocol for individuals who want metabolic support without the clinical intervention.
None. NAD+ supports metabolic pathways through a mechanism that does not produce nausea, vomiting, or the muscle catabolism associated with aggressive caloric restriction protocols.
Equivalent bioavailability through both routes. Nasal is faster for acute application. Sublingual allows for more controlled dosing. Both bypass first-pass metabolism.